共 50 条
- [41] Re: Does Benign Prostatic Hyperplasia Treatment with Alpha-Blockers Affect Prostate Cancer Risk? Editorial Comment [J]. JOURNAL OF UROLOGY, 2013, 190 (06): : 2096 - 2096
- [44] Re: HoLEP: The New Gold Standard for Surgical Treatment of Benign Prostatic Hyperplasia Editorial Comment [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : 1127 - 1127
- [45] Re: Development of a Quality of Life Scale Specific for Patients with Benign Prostatic Hyperplasia Editorial Comment [J]. JOURNAL OF UROLOGY, 2014, 192 (02): : 492 - 492
- [46] Re: Cost-Effectiveness of Combination Therapy for Treatment of Benign Prostatic Hyperplasia: A Model Based on the Findings of the Combination of Avodart and Tamsulosin Trial Editorial Comment [J]. JOURNAL OF UROLOGY, 2012, 188 (04): : 1237 - 1238
- [47] Re: Survey of Overactive Bladder Symptoms Influencing Bother Before and After Treatment with Tamsulosin Hydrochloride in Japanese Patients with Benign Prostatic Hyperplasia Editorial Comment [J]. JOURNAL OF UROLOGY, 2012, 188 (03): : 897 - 897
- [49] Extraperitoneal Laparoscopic Adenomectomy for Benign Prostatic Hyperplasia Editorial Comment [J]. JOURNAL OF UROLOGY, 2010, 184 (01): : 230 - 230